Floatz logo

Therapeutic Asset Ratings

622 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Plavix
Breast Cancer
European Institute of OncologyD (26)
Pomalidomide
Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical SciencesD (26)
Promestriene
Breast Cancer
Federal University of São PauloN/AD (26)
Propylthiouracil
Breast Cancer
Hospices Civils de LyonD (26)
Qibei Jiedu Formula
Breast Cancer
LI FENGN/AD (26)
Shenbailing
Breast Cancer
Caigang LiuN/AD (26)
SULFAMETHOXAZOLE
Breast Cancer
University of AlbertaN/AD (26)
Tapentadol
Breast Cancer
Shaukat Khanum Memorial Cancer Hospital & Research CentreN/AD (26)
TECHNETIUM-99
Breast Cancer
Omphis FoundationD (26)
TECHNETIUM, TC-99M
Breast Cancer
Isabelle HenskensN/AD (26)
TECHNETIUM TC 99M SESTAMIBI
Breast Cancer
M.D. Anderson Cancer CenterN/AD (26)
Teriflunomide
Breast Cancer
Institut du Cancer de Montpellier - Val d'AurelleN/AD (26)
Tisagenlecleucel
Breast Cancer
National Cancer Institute (NCI)D (26)
Trimethoprim
Breast Cancer
University of AlbertaN/AD (26)
Voriconazole
Breast Cancer
Beni-Suef UniversityD (26)
Xihuang Pill
Breast Cancer
Zhejiang Provincial People's HospitalN/AD (26)
Talniflumate
Breast Cancer
Shandong UniversityP4NR (0)
Gcmaf Injections
Breast Cancer
S.LAB (SOLOWAYS)P3NR (0)
Pcbhp
Breast Cancer
Fudan UniversityP3NR (0)
Tgfbr2 Ko Ic9/Trop2.Car/Il-15 Nk Cells
Breast Cancer
M.D. Anderson Cancer CenterP1NR (0)
TROP2.CAR
Breast Cancer
M.D. Anderson Cancer CenterP1NR (0)
hp568
Breast Cancer
Hinova Pharmaceuticals Inc.P1/2NR (0)
Showing 601 to 622 of 622 assets
PreviousPage 25 of 25Next